Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Novel Role of Raft-Associated Smoothened (SMO) in AKT Signal Regulation in Diffuse Large B Cell Lymphoma

Nitin Agarwal, PhD, Kranthi Kunkalla, Daniel Bilbao, PhD, Ralf Landgraf, PhD, Francisco Vega, MD PhD

Blood (2019) 134 (Supplement_1): 3972.

https://doi.org/10.1182/blood-2019-121847

Published: 2019

Journal Articles

Identification of Target Pathways Induced By the Multiple Myeloma Tumor Microenvironment Using Activity-Based Protein Profiling and Ex Vivo Protein Kinase Inhibitor Screening

Mark B Meads, PhD, Paula Oliveira, BS, Allison Distler, B.S., Maria Silva, M.Sc, Karen Burger, PhD, Bin Fang, PhD, Aunshka Collins, BS, John L. Cleveland, PhD, John M. Koomen, PhD, Ariosto Silva, PhD, Dmitri Rebatchouk, PhD, Kenneth H. Shain, MD PhD, William R. Roush, PhD

Blood (2016) 128 (22): 3288.

https://doi.org/10.1182/blood.V128.22.3288.3288

Published: 2016

Journal Articles

Different Impact of Expression Levels of IGFBP2 and IGFBP7 on Survival and Relapse Rate in Acute Promyelocytic Leukemia

Anna Hecht, Daniel Nowak, MD, Florian Nolte, Verena Nowak, Julia Oblaender, Thomas Buechner, Karsten Spiekermann, Wolf-Karsten Hofmann, MD, Eva Lengfelder, MD

Blood (2015) 126 (23): 1382.

https://doi.org/10.1182/blood.V126.23.1382.1382

Published: 2015

Journal Articles

A Novel Simulation Method for Mapping Dysregulated Pathways and Predicting Effective Therapeutics in the Myelodysplastic Syndromes

Christopher R. Cogle, MD, Kaoru Tohyama, MD PhD, Shireen Vali, PhD, Ansu Kumar, Neeraj Kumar Singh, Krishna Kumar Tiwari, Anuj Tyagi, Taher Abbasi, MS, Peter P. Sayeski, PhD

Blood (2014) 124 (21): 5595.

https://doi.org/10.1182/blood.V124.21.5595.5595

Published: 2014

Journal Articles

Therapy Personalization Using Predictive Simulation Approach with Ex-Vivo Clinical Validations

Nicole A Doudican, PhD, Ravi Vij, MD, Mark A Fiala, BS, CCRP, Justin King, Shireen Vali, PhD, Kabya Basu, Ansu Kumar, Neeraj Kumar Singh, Zeba Sultana, Taher Abbasi, MS, Amitabha Mazumder, MD

Blood (2014) 124 (21): 2232.

https://doi.org/10.1182/blood.V124.21.2232.2232

Published: 2014

Journal Articles

High-Resolution Chromatin Immunoprecipitation (ChIP) Sequencing Identifies Novel Binding Targets and Prognostic Role for SOX11 in Mantle Cell Lymphoma

Pei-Yu Kuo, MS, Violetta V. Leshchenko, PhD, Tobias A. Gellen, Netha Ulahannan, MS, Paul Zumbo, BA, BS, Christopher E. Mason, PhD, Wyndham H. Wilson, MD, PhD, Adrian Wiestner, MD, PhD, K. Stephen Suh, PhD, Andre Goy, MD, David T. Yang, MD, Brad S. Kahl, MD, Randy D. Gascoyne, MD, Ari Melnick, MD, Samir Parekh, MD

Blood (2011) 118 (21): 585.

https://doi.org/10.1182/blood.V118.21.585.585

Published: 2011

Journal Articles

ROR1 Isoforms Are Constitutively Phosphorylated in Chronic Lymphocytic Leukemia (CLL) - a Survival Factor for CLL Cells

Hakan Mellstedt, MD, PhD., Mohammad Hojjat-Farsangi, PhD, Ladan Mansouri, MD, Anders Osterborg, MD, PhD, Hodjattallah Rabbani, PhD

Blood (2011) 118 (21): 1778.

https://doi.org/10.1182/blood.V118.21.1778.1778

Published: 2011

Journal Articles

Developmental Differences In the Let-7b/IMP-1/IGF-II Axis contribute to the High Proliferative Rate of Neonatal Megakaryocyte Progenitors.

Ravi K. Gutti, PhD, Hannes Sallmon, Zhi-Jian Liu, PhD, Francisca Ferrer-Marin, MD, PhD, Alan Cantor, MD, PhD, Matthew Bailey, BS, Martha Sola-Visner, MD

Blood (2010) 116 (21): 1598.

https://doi.org/10.1182/blood.V116.21.1598.1598

Published: 2010

Journal Articles

p53-Inducible Micrornas 192 and 215 Regulate p53 Expression and IGF1 Axis in Multiple Myeloma.

Flavia Pichiorri, PhD, MSC, Sung-Suk Suh, Luciana De Luca, Cristian Taccioli, Don Benson, MD, PhD, Craig Hofmeister, MD, Rami Aqeilan, Carlo M. Croce, MD

Blood (2009) 114 (22): 1973.

https://doi.org/10.1182/blood.V114.22.1973.1973

Published: 2009

Journal Articles

Metabolic Endocrine Regulators of Hematopoietic Stem Cell Formation and Function.

James Harris, Claire C Cutting, Michael Dovey, Wolfram Goessling, MD, PhD, Trista North, PhD

Blood (2009) 114 (22): 1496.

https://doi.org/10.1182/blood.V114.22.1496.1496

Published: 2009

Journal Articles

Developmental Stage-Specific Interplay Between GATA1 and IGF Signaling in Fetal Hematopoiesis and Leukemogenesis.

Jan-Henning Klusmann, MD, Frank Godinho, Kirsten Heitmann, Aliaksandra Maroz, Dirk Reinhardt, MD, PhD, Stuart H Orkin, MD, Zhe Li, PhD

Blood (2009) 114 (22): 386.

https://doi.org/10.1182/blood.V114.22.386.386

Published: 2009

Journal Articles

FANCD2 Participates in JAK2-Dependent Activation of STAT5a

Grover C. Bagby, Jr., MD, Laura E Hays, PhD

Blood (2008) 112 (11): 444.

https://doi.org/10.1182/blood.V112.11.444.444

Published: 2008

Journal Articles

Modification of IGF1R Expression on Malignant Lymphoid Cells by a Proteasome Inhibitor

Yasuhito Terui, MD, PhD, Yuji Mishima, Yuko Mishima, Kiyohiko Hatake, MD, PhD

Blood (2008) 112 (11): 5037.

https://doi.org/10.1182/blood.V112.11.5037.5037

Published: 2008

Journal Articles

Insulin-like growth factor-1 potentiates platelet activation via the IRS/PI3Kα pathway

Ingeborg Hers

Blood (2007) 110 (13): 4243–4252.

https://doi.org/10.1182/blood-2006-10-050633

Published: 2007

Journal Articles

Kinome and Druggable Genome Vulnerabilities in Multiple Myeloma Identified by Systematic RNA Interference Screening.

Rodger E. Tiedemann, MD, PhD, Yuan-Xiao Zhu, PhD, Holly Yin, PhD, Quick Que, PhD, Chang-Xin Shi, PhD, Spyro Mousses, PhD, Keith Stewart, MD

Blood (2007) 110 (11): 391.

https://doi.org/10.1182/blood.V110.11.391.391

Published: 2007

Journal Articles

Insuline-Like Growth Factor 1 Is over Expressed in Multiple Myeloma Plasma Cells and Regulates the Expression of the Insuline-Like Growth Factor 1 Receptor.

C. Terragna, M. Renzulli, N. Testoni, T. Grafone, P. Tosi, E. Zamagni, C. Cellini, E. Ottaviani, S. Colarossi, I. Iacobucci, A. Poerio, G. Martinelli, M. Baccarani, M. Cavo

Blood (2005) 106 (11): 4363.

https://doi.org/10.1182/blood.V106.11.4363.4363

Published: 2005

Journal Articles

Insulin-Like Growth Factor II Is an Autocrine Growth Factor To Prevent Apoptosis as Well as To Enhance Proliferation and Maturation of Erythroid Progenitor Cells.

Taro Nagatomo, MD, PhD, Koichiro Muta, MD, PhD, Shouichi Ohga, MD, PhD, Masayuki Ochiai, MD, Shunji Hikino, MD, PhD, Toshiro Hara, MD, PhD

Blood (2005) 106 (11): 3140.

https://doi.org/10.1182/blood.V106.11.3140.3140

Published: 2005

Journal Articles

Differential Gene Expression Profiles of Cord Blood Lineage-Negative Cells Prior to and Following Selective Amplification.

Meng-jiao Shi, PhD, Jason Hermann, BS, Joseph Laning, PhD, Henry Hoppe, PhD, Morey Kraus, PhD, Jan W.M. Visser, PhD

Blood (2004) 104 (11): 4141.

https://doi.org/10.1182/blood.V104.11.4141.4141

Published: 2004

NARROW

Novel Role of Raft-Associated Smoothened (SMO) in AKT Signal Regulation in Diffuse Large B Cell Lymphoma

Identification of Target Pathways Induced By the Multiple Myeloma Tumor Microenvironment Using Activity-Based Protein Profiling and Ex Vivo Protein Kinase Inhibitor Screening

Different Impact of Expression Levels of IGFBP2 and IGFBP7 on Survival and Relapse Rate in Acute Promyelocytic Leukemia

A Novel Simulation Method for Mapping Dysregulated Pathways and Predicting Effective Therapeutics in the Myelodysplastic Syndromes

Therapy Personalization Using Predictive Simulation Approach with Ex-Vivo Clinical Validations

High-Resolution Chromatin Immunoprecipitation (ChIP) Sequencing Identifies Novel Binding Targets and Prognostic Role for SOX11 in Mantle Cell Lymphoma

ROR1 Isoforms Are Constitutively Phosphorylated in Chronic Lymphocytic Leukemia (CLL) - a Survival Factor for CLL Cells

Developmental Differences In the Let-7b/IMP-1/IGF-II Axis contribute to the High Proliferative Rate of Neonatal Megakaryocyte Progenitors.

p53-Inducible Micrornas 192 and 215 Regulate p53 Expression and IGF1 Axis in Multiple Myeloma.

Metabolic Endocrine Regulators of Hematopoietic Stem Cell Formation and Function.

Developmental Stage-Specific Interplay Between GATA1 and IGF Signaling in Fetal Hematopoiesis and Leukemogenesis.

FANCD2 Participates in JAK2-Dependent Activation of STAT5a

Modification of IGF1R Expression on Malignant Lymphoid Cells by a Proteasome Inhibitor

Insulin-like growth factor-1 potentiates platelet activation via the IRS/PI3Kα pathway

Kinome and Druggable Genome Vulnerabilities in Multiple Myeloma Identified by Systematic RNA Interference Screening.

Insuline-Like Growth Factor 1 Is over Expressed in Multiple Myeloma Plasma Cells and Regulates the Expression of the Insuline-Like Growth Factor 1 Receptor.

Insulin-Like Growth Factor II Is an Autocrine Growth Factor To Prevent Apoptosis as Well as To Enhance Proliferation and Maturation of Erythroid Progenitor Cells.

Differential Gene Expression Profiles of Cord Blood Lineage-Negative Cells Prior to and Following Selective Amplification.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only